Low-dose naltrexone for pruritus in systemic sclerosis

International Journal of Rheumatology

Volumn 2011, Issue , 2011, Pages

  Frech, Tracy ^a   Novak, Kirsten ^b   Revelo, Monica P ^a   Murtaugh, Maureen ^a   Markewitz, Boaz ^a   Hatton, Nathan ^a   Scholand, Mary Beth ^a   Frech, Edward ^c   Markewitz, David ^d   Sawitzke, Allen D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Mountain West Gastroenterology   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; NALTREXONE;

ADULT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DIFFUSE SCLERODERMA; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; INSOMNIA; LIMITED SCLERODERMA; LOW DRUG DOSE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RAYNAUD PHENOMENON; SCORING SYSTEM; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

EID: 81555209755     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2011/804296     Document Type: Article

References (29)

1. Weisshaar E., Kucenic M. J., Fleischer A. B. Jr., Pruritus: a review Acta Dermato-Venereologica, Supplement 2003 213 5 32 (Pubitemid 36629840)
2. Steen V. D., Clinical manifestations of systemic sclerosis Seminars in Cutaneous Medicine and Surgery 1998 17 1 48 54 (Pubitemid 28127890)
3. Razykov I., Thombs B. D., Hudson M., Bassel M., Baron M., Prevalence and clinical correlates of pruritus in patients with systemic sclerosis Arthritis and Rheumatism 2009 61 12 1765 1770
4. Verhoeven E. W., de Klerk S., Kraaimaat F. W., van de Kerkhof P. C. M., de Jong E. M., Evers A. W. M., Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review Acta Dermato-Venereologica 2008 88 3 211 218 (Pubitemid 351743861)
5. Jacobsen S., Halberg P., Ullman S., Van Venrooij W. J., Hier-Madsen M., Wiik A., Petersen J., Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis British Journal of Rheumatology 1998 37 1 39 45
6. Cash W. J., McCance D. R., Young I. S., McEneny J., Cadden I. S., McDougall N. I., Callender M. E., Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk Hepatology Research 2010 40 11 1098 1106
7. Kumagi T., Heathcote E. J., Primary biliary cirrhosis Orphanet Journal of Rare Diseases 2008 3 1, article 1
8. Younger J., Mackey S., Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study Pain Medicine 2009 10 4 663 672
9. Gironi M., Martinelli-Boneschi F., Sacerdote P., Solaro C., Zaffaroni M., Cavarretta R., Moiola L., Bucello S., Radaelli M., Pilato V., Rodegher M. E., Cursi M., Franchi S., Martinelli V., Nemni R., Comi G., Martino G., A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis Multiple Sclerosis 2008 14 8 1076 1083
10. Smith J. P., Stock H., Bingaman S., Mauger D., Rogosnitzky M., Zagon I. S., Low-dose naltrexone therapy improves active Crohn's disease American Journal of Gastroenterology 2007 102 4 820 828 (Pubitemid 46496605)
11. Jones E. A., Neuberger J., Bergasa N. V., Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions QJM 2002 95 8 547 552 (Pubitemid 34919145)
12. Hutchinson M. R., Zhang Y., Brown K., Coats B. D., Shridhar M., Sholar P. W., Patel S. J., Crysdale N. Y., Harrison J. A., Maier S. F., Rice K. C., Watkins L. R., Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4) European Journal of Neuroscience 2008 28 1 20 29
13. San-Emeterio E. P., Hurlé M. A., Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice Neuroscience Letters 2006 403 3 276 279 (Pubitemid 44016008)
14. Masi A. T., Rodnan G. P., Medsger T. A., Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee Arthritis and Rheumatism 1980 23 5 581 590
15. Bieri D., Reeve R. A., Champion G. D., Addicoat L., Ziegler J. B., The faces pain scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties Pain 1990 41 2 139 150 (Pubitemid 20179927)
16. Gupta M. A., Gupta A. K., Schork N. J., Ellis C. N., Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria Psychosomatic Medicine 1994 56 1 36 40 (Pubitemid 24054871)
17. Khanna D., Hays R. D., Maranian P., Seibold J. R., Impens A., Mayes M. D., Clements P. J., Getzug T., Fathi N., Bechtel A., Furst D. E., Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument Arthritis and Rheumatism 2009 61 9 1257 1263
18. Khanna D., Hays R. D., Park G. S., Braun-Moscovici Y., Mayes M. D., McNearney T. A., Hsu V., Clements P. J., Furst D. E., Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument Arthritis and Rheumatism 2007 57 7 1280 1286 (Pubitemid 47585475)
19. Bodukam V., Hays R. D., Maranian P., Furst D. E., Seibold J. R., Impens A., Mayes M. D., Clements P. J., Khanna D., Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis Rheumatology 2011 50 2 330 334
20. Steen V. D., Medsger T. A. Jr., Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis Arthritis and Rheumatism 1998 41 9 1613 1619 (Pubitemid 28459919)
21. Khanna D., Furst D. E., Hays R. D., Park G. S., Wong W. K., Seibold J. R., Mayes M. D., White B., Wigley F. F., Weisman M., Barr W., Moreland L., Medsger T. A., Steen V. D., Martin R. W., Collier D., Weinstein A., Lally E. V., Varga J., Weiner S. R., Andrews B., Abeles M., Clements P. J., Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study Annals of the Rheumatic Diseases 2006 65 10 1325 1329 (Pubitemid 44620441)
22. Stnder S., Raap U., Weisshaar E., Schmelz M., Mettang T., Handwerker H., Luger T. A., Pathogenese des Pruritus Journal of the German Society of Dermatology 2011 9 6 456 463
23. El-Baalbaki G., Razykov I., Hudson M., Bassel M., Baron M., Thombs B. D., Association of pruritus with quality of life and disability in systemic sclerosis Arthritis Care and Research 2010 62 10 1489 1495
24. Rashtak S., Pittelkow M., Skin involvement in systemic autoimmune diseases Current Directions in Autoimmunity 2008 10 344 358
25. Wiedermann C. J., Sacerdote P., Propst A., Propst T., Judmaier G., Kathrein H., Vogel W., Panerai A. E., Decreased -endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease Brain, Behavior and Immunity 1994 8 3 261 269 (Pubitemid 24344874)
26. Sharafaddinzadeh N., Moghtaderi A., Kashipazha D., Majdinasab N., Shalbafan B., The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial Multiple Sclerosis 2010 16 8 964 969
27. Frieri M., Systemic sclerosis. The role of the mast cell and cytokines Annals of Allergy 1992 69 5 385 392
28. Claman H. N., On scleroderma: mast cells, endothelial cells, and fibroblasts Journal of the American Medical Association 1989 262 9 1206 1209 (Pubitemid 19206697)
29. Walker M. M., Warwick A., Ung C., Talley N. J., The role of eosinophils and mast cells in intestinal functional disease Current Gastroenterology Reports 2011 13 4 323 330